We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+34.57%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$712M
AUM Growth
+$90.4M
Cap. Flow
+$220K
Cap. Flow %
0.03%
Top 10 Hldgs %
33.84%
Holding
126
New
27
Increased
25
Reduced
33
Closed
22

Top Buys

Rank Stock Value
1
CATX icon
Perspective Therapeutics
CATX
+$10.6M
2
BBIO icon
BridgeBio Pharma
BBIO
+$10.3M
3
HELP
Cybin Inc
HELP
+$9.73M
4
S icon
SentinelOne
S
+$8.81M
5
JSPR icon
Jasper Therapeutics
JSPR
+$7.71M

Top Sells

Rank Stock Value
1
NVMI
Nova
NVMI
+$15.3M
2
ATXS
Astria Therapeutics
ATXS
+$12.9M
3
TSEM icon
Tower Semiconductor
TSEM
+$10.9M
4
INBX
Inhibrx, Inc. Common Stock
INBX
+$8.61M
5
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$7.61M

Sector Composition

Rank Sector Weight
1 Healthcare 65.19%
2 Technology 15.63%
3 Communication Services 2.68%
4 Consumer Discretionary 2.45%
5 Utilities 0.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVS icon
51
Novartis
NVS
$297B
$4.84M 0.68%
50,000
-10,000
-17% -$1.03M
CPRX
52
DELISTED
Catalyst Pharmaceutical
CPRX
$4.59M 0.65%
+288,000
New +$4.34M
GSK icon
53
GSK
GSK
$104B
$4.29M 0.6%
100,000
– –
VTGN icon
54
VistaGen Therapeutics
VTGN
$9.89M
$4.27M 0.6%
808,550
– –
APLT
55
DELISTED
Applied Therapeutics
APLT
$4.21M 0.59%
+619,029
New +$2.78M
HOWL icon
56
Werewolf Therapeutics
HOWL
$17.2M
$4.06M 0.57%
626,810
– –
AKRO
57
DELISTED
Akero Therapeutics
AKRO
$4.05M 0.57%
+160,445
New +$3.85M
SHLT
58
DELISTED
SHL Telemedicine Ltd American Depositary Shares
SHLT
$3.86M 0.54%
632,456
– –
PLRX icon
59
Pliant Therapeutics
PLRX
$64.4M
$3.85M 0.54%
258,554
+65,000
+34% +$1.07M
PMN icon
60
ProMIS Neurosciences
PMN
$123M
$3.5M 0.49%
73,362
– –
SWTX
61
DELISTED
SpringWorks Therapeutics
SWTX
$3.46M 0.49%
70,269
-100,001
-59% -$4.62M
ALEC icon
62
Alector
ALEC
$168M
$3.37M 0.47%
+560,000
New +$3.66M
IRON icon
63
Disc Medicine
IRON
$2.96B
$3.04M 0.43%
+48,886
New +$3.17M
AAPL icon
64
Apple
AAPL
$4.54T
$3M 0.42%
+17,500
New +$3.18M
ALNY icon
65
CALL
Alnylam Pharmaceuticals
ALNY
$27.5B
$2.99M 0.42%
20,000
– –
ENLT icon
66
Enlight Renewable Energy
ENLT
$11.8B
$2.86M 0.4%
169,280
– –
SEDG icon
67
SolarEdge
SEDG
$2.51B
$2.85M 0.4%
40,175
-7,825
-16% -$565K
RARE icon
68
CALL
Ultragenyx Pharmaceutical
RARE
$2.45B
$2.57M 0.36%
+55,000
New +$2.59M
RZLT icon
69
Rezolute
RZLT
$454M
$2.54M 0.36%
996,710
– –
QCOM icon
70
Qualcomm
QCOM
$155B
$2.54M 0.36%
+15,000
New +$2.32M
PFE icon
71
Pfizer
PFE
$143B
$2.5M 0.35%
90,000
– –
ACAD icon
72
Acadia Pharmaceuticals
ACAD
$4.43B
$2.31M 0.32%
+125,000
New +$3.1M
ELEV
73
DELISTED
Elevation Oncology
ELEV
$2.21M 0.31%
430,000
-470,000
-52% -$1.52M
ESTC icon
74
Elastic
ESTC
$6.84B
$2M 0.28%
+20,000
New +$2.3M
AMD icon
75
Advanced Micro Devices
AMD
$776B
$1.99M 0.28%
11,000
-39,387
-78% -$6.89M
1 2
3
4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q1 2024 Portfolio in Review

As of Q1 2024, Sphera Funds Management held 126 positions worth $712M, up 15% from $621M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Sphera Funds Management's Q1 2024 filing shows 27 new, 25 increased, 33 reduced and 22 closed positions. Its largest new stake was Cybin Inc: 673,195 shares worth $10.6M. The largest sale was Nova, an estimated $15.3M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 63% a quarter earlier, followed by Technology and Communication Services.

  • Sphera Funds Management's largest Q1 2024 buy was Cybin Inc: 673,195 shares worth $10.6M.
  • Sphera Funds Management added most to Perspective Therapeutics in Q1 2024, an estimated $10.6M increase.
  • Sphera Funds Management's biggest Q1 2024 reduction was Nova, cutting an estimated $15.3M.
  • Sphera Funds Management fully exited Inhibrx, Inc. Common Stock in Q1 2024, selling an estimated $8.61M.
  • Sphera Funds Management's ten largest holdings make up 34% of its $712M portfolio in Q1 2024.
  • Sphera Funds Management opened 27 new positions and closed 22 in Q1 2024.
  • Sphera Funds Management's portfolio value rose 15% quarter-over-quarter to $712M.

Based on Sphera Funds Management's 13F filing for Q1 2024, filed 15 May 2024.